Search Results for 'stroke tia'

stroke tia published presentations and documents on DocSlides.

Rethinking TIA  and Minor Stroke
Rethinking TIA and Minor Stroke
by molly
S. Claiborne Johnston, MD, PhD. Dell Medical Schoo...
Approach to TIA and Management of Stroke after 4.5 hours
Approach to TIA and Management of Stroke after 4.5 hours
by briana-ranney
Approach to TIA and Management of Stroke after 4....
Can we safely discharge TIA patients?
Can we safely discharge TIA patients?
by min-jolicoeur
Louis Muller. EM Registrar. January 2010. Objecti...
Welcome to the TIA Clinic
Welcome to the TIA Clinic
by elise
Preventing stroke. Primary prevention & lifest...
 Stroke and TIA Evaluations in Neurologically Underserved Regions
Stroke and TIA Evaluations in Neurologically Underserved Regions
by tatiana-dople
Ganesh Asaithambi, MD. John . Nasseff. Neuroscie...
Ontario Triage Algorithm for Stroke Prevention Clinic Referrals
Ontario Triage Algorithm for Stroke Prevention Clinic Referrals
by amber
Patients with TIA or Non Disabling Stroke Symptoms...
Stroke & TIA SAPMEA PROJECT ECHO | Neurology SERIES
Stroke & TIA SAPMEA PROJECT ECHO | Neurology SERIES
by adia
Stroke Resources for health Professionals. Stroke ...
Update from education  committee
Update from education committee
by mastervisa
Train the trainer—content reviewed from. Transie...
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
by eloise
ORIGIN. Pierre . Amarenco. , Hans . Denison. , . S...
Risk of stroke and transient
Risk of stroke and transient
by shepherd
ischaemic. attack in patients with. a diagnosis o...
PREVENTION OF STROKE
PREVENTION OF STROKE
by harmony
-24- Primary prevention refers to those activiti...
Addressing Patients with Cryptogenic Stroke
Addressing Patients with Cryptogenic Stroke
by williams
Epidemiology, Pathophysiology, Diagnosis and Follo...
Stroke Services for London
Stroke Services for London
by maisie
Rachel Tyndall SROPresentation to OSC 4 February 2...
Recognizing Stroke  FAST
Recognizing Stroke FAST
by celsa-spraggs
:. F. ace . A. rms . S. peech . T. ime. You an...
Recognizing Stroke  FAST
Recognizing Stroke FAST
by stefany-barnette
:. F. ace . A. rms . S. peech . T. ime. You an...
Risk Factor Modification Post Stroke
Risk Factor Modification Post Stroke
by olivia-moreira
Ron Pellegrino, MD. November 20, 2015. Objectives...
Screening for Cognitive Impairment in Stroke and TIA
Screening for Cognitive Impairment in Stroke and TIA
by celsa-spraggs
. October 2013. Acknowledgements. Rebecca Fleck,...
Assessment Tools in Stroke and Transient Ischaemic Attack (TIA) Dr Dwa
Assessment Tools in Stroke and Transient Ischaemic Attack (TIA) Dr Dwa
by lindy-dunigan
1 dwai_sen@yahoo.com Stroke and Transient ischemi...
Antiplatelet
Antiplatelet
by kittie-lecroy
Therapy for the Secondary Prevention of . Cerebr...
Antiplatelet
Antiplatelet
by sherrill-nordquist
Therapy for the Secondary Prevention of . Cerebr...
ASRH Site Visit Presentation Template
ASRH Site Visit Presentation Template
by stefany-barnette
Use this template to build your presentation for ...
Pharmacologic Profiles  of Approved and Investigational Oral
Pharmacologic Profiles of Approved and Investigational Oral
by kinohear
Anticoagulants.  . Warfarin. Dabigatran. Rivaroxa...
Neurology What not to miss in the ER
Neurology What not to miss in the ER
by melody
Danielle . Pirrie. CCPA. Toronto East General Hos...
Cost effectiveness of AF monitoring strategies in a
Cost effectiveness of AF monitoring strategies in a
by wang
post-stroke population. Lauren E. . Cipriano. Jeff...
6 th  May, 2022, 10.30am
6 th May, 2022, 10.30am
by Shadowlord
European Stroke Organisation Conference, Lyon. Gui...
Kalani R Wells, APRN, MSN, ACNP-BC, CNRN
Kalani R Wells, APRN, MSN, ACNP-BC, CNRN
by pamella-moone
Neurologic Associates, Ltd.. AANN Neuroscience Nu...
 IMPACT- AFib : An 80,000 Person Randomized Trial Using the
IMPACT- AFib : An 80,000 Person Randomized Trial Using the
by celsa-spraggs
FDA Sentinel System Platform . Richard Platt, MD,...
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...